Citigroup’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-200,800
Closed -$42.7M 7874
2014
Q4
$42.7M Buy
200,800
+34,500
+21% +$6.86M 0.04% 462
2014
Q3
$29.6M Buy
166,300
+5,800
+4% +$963K 0.03% 606
2014
Q2
$27.2M Buy
160,500
+113,900
+244% +$17.7M 0.03% 620
2014
Q1
$5.78M Sell
46,600
-73,300
-61% -$8.93M 0.01% 1589
2013
Q4
$13.3M Buy
119,900
+43,800
+58% +$4.18M 0.01% 1027
2013
Q3
$6.88M Sell
76,100
-12,800
-14% -$1.15M 0.01% 1480
2013
Q2
$7.49M Buy
+88,900
New +$9.22M 0.01% 1302

Other funds holding AGN

Citigroup's AGN Position: Q1 2015 in Review

Citigroup sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 98,646 shares — an estimated $21M sold.

Citigroup first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $29.4M in Q2 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Citigroup reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Citigroup sold 98,646 Allergan Inc shares in Q1 2015, an estimated $21M.
  • Citigroup first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Citigroup's Allergan Inc position peaked at $29.4M in Q2 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Citigroup's 13F filing for Q1 2015, filed 14 May 2015.